A Danish study recently showed that legal blindness attributable to AMD has halved since the introduction of anti-VEGF therapies and an Israeli study showed a reduction in overall blindness over time after anti-VEGF therapy [7], [8]. This evidence concerns the gene VEGFA and age-related macular degeneration.